Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 80% · stale
- Computed at
- 2026-08-20T10:53:38.312698+00:00
- Claimed
- 85
- Reported
- 84
- Verified
- 76
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Adopt with guardrails
- Why
- FDA-cleared (Jan 2024) and commercially live with a strong sham-controlled PDN signal (72.3% responder at day 30 vs 0% sham, p<0.0001), but the evidence base is thin (one small pivotal trial) and durability depends on recurring treatment.
- Next
- Track post-market PDN data and any second pivotal RCT; treat single-trial responder rates as provisional and require sham-controlled replication before citing efficacy externally. Watch CMS coverage outcome.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 13
- Tier 1
- 4
- Tier 2
- 2
- Tier 3
- 7
- Supports
- 7
- Contradicts
- 2
- Context
- 4
- Latest observed
- 2025-05-02
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-19 Reading moved from mature to mature.